homeostasis/metabolism
|
• slight increase in blood glucose concentration (165 mg/dl vs. 132 mg/dl in wild-type)
|
|
hm1
|
Gcktm1.1Mgn/Gcktm1.1Mgn
129S6/SvEvTac-Gcktm1.1Mgn |
|
|||||||||||||||||
|
• slight increase in blood glucose concentration (165 mg/dl vs. 132 mg/dl in wild-type)
|
|
hm2
|
Gcktm1.1Mgn/Gcktm1.1Mgn
involves: 129S6/SvEvTac * C57BL/6 |
|
|||||||||||||||||
|
• about 10% increase in blood glucose concentration (194 mg/dl vs. 175 mg/dl in wild-type)
|
|
cn3
|
Gcktm1.1Mgn/Gcktm1.1Mgn Tg(Ins2-cre)25Mgn/0 involves: 129S6/SvEvTac * C57BL/6 * DBA/2 |
|
|||||||||||||||||
|
• more than 80% neonatal mortality as a result of severe hyperglycemia
|
|
• highly variable but increased blood glucose concentrations
|
|
• decreased by about 70%
|
|
• diminished hepatic glycogen
|
Mouse Models of Human Disease |
OMIM ID | Ref(s) | |
| Maturity-Onset Diabetes of the Young, Type 2; MODY2 | 125851 | J:51826 | |
|
cn4
|
Gcktm1.1Mgn/Gck+ Tg(Ins2-cre)25Mgn/0 involves: 129S6/SvEvTac * C57BL/6 * DBA/2 |
|
|||||||||||||||||
|
• 70% decrease in insulin secretion during hyperglycemic clamp studies
|
|
• blood glucose concentration is increased by about 50% compared to heterozygous Gcktm1.1Mgn mice
• under fasting conditions, have a 25% increase in blood glucose concentration, without differences in basal insulin concentration
|
|
• glucose turnover and glucose infusion rates during hyperglycemic clamp are reduced by about 60 and 70%, respectively
|
|
• net glycogen synthesis in liver is reduced by about 50% during hyperglycemic clamp studies
|
|
• 70% decrease in insulin secretion during hyperglycemic clamp studies
|
Mouse Models of Human Disease |
OMIM ID | Ref(s) | |
| Maturity-Onset Diabetes of the Young, Type 2; MODY2 | 125851 | J:51826 | |
|
cn5
|
Gcktm1.1Mgn/Gcktm1.1Mgn Tg(Alb-cre)21Mgn/0 involves: 129S6/SvEvTac * C57BL/6 * DBA/2 |
|
|||||||||||||||||
|
• secrete 70% less insulin in response to glucose stimulus
|
|
• 10% increase in fed blood glucose concentration
|
|
• post-absorptive (fed) plasma insulin concentrations twice that of controls
|
|
• glucose turnover and glucose infusion rates during hyperglycemic clamp are reduced
|
|
• net hepatic glycogen synthesis is reduced by about 90% during hyperglycemic clamp studies
|
|
• mild insulin resistance
|
|
• secrete 70% less insulin in response to glucose stimulus
|
Mouse Models of Human Disease |
OMIM ID | Ref(s) | |
| Maturity-Onset Diabetes of the Young, Type 2; MODY2 | 125851 | J:51826 | |